By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Metabolic Pharmaceuticals Limited 

Level 3, 509 St. Kilda Road

Melbourne  Victoria  3004  Australia
Phone: 61-3-9860-5700 Fax: 61-3-9860-5777



Company News
Metabolic Pharmaceuticals (MBP.AX) Denies Soccer Players Were Part of Secret Drug Trial 7/29/2013 8:50:02 AM
Metabolic Pharmaceuticals (MBP.AX)'s Obesity Trial Update: First 100 Subjects Complete The Phase 2B Trial Of AOD9604 10/5/2006 11:26:05 AM
Metabolic Pharmaceuticals (MBP.AX)'s Neuropathic Pain Drug, ACV1, Enters Phase 2 Clinical Trials 9/28/2006 11:20:32 AM
Metabolic Pharmaceuticals (MBP.AX) To Present At The Rodman & Renshaw Techvest 7th Annual Healthcare Conference 11/3/2005 11:51:38 AM
Metabolic Pharmaceuticals (MBP.AX) Initiates Recruitment For Phase II-B Clinical Trial Of AOD9604 Obesity Drug10/19/2005 5:13:22 PM
Neuren Pharmaceuticals Limited And Metabolic Pharmaceuticals (MBP.AX) Collaborate To Develop Range Of Nerve Repair Compounds With Support From New Zealand Government10/19/2005 5:12:56 PM
Metabolic Pharmaceuticals (MBP.AX) Appoints New Chief Executive Officer10/19/2005 5:12:32 PM
Metabolic Pharmaceuticals (MBP.AX) Shares Partnering Prospects For AOD9604 For Obesity10/19/2005 5:12:30 PM
Metabolic Pharmaceuticals (MBP.AX) Reports Positive Results From Its Phase 2b Obesity Trial; Fat Burning Pill Effective10/19/2005 5:12:26 PM
Metabolic Pharmaceuticals (MBP.AX) , Circadian Technologies Limited (CIR.AX) Trading Halted Ahead Of Trial Results10/19/2005 5:12:25 PM